Molecular Templates logo
Molecular Templates MTEM

Quarterly report 2024-Q2
added 08-14-2024

report update icon

Molecular Templates Cash Conversion Cycle 2011-2026 | MTEM

Quarterly Cash Conversion Cycle Molecular Templates

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - - - - - - - - - - - - - - - - - - 212 - - - 2.68 - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
212 2.68 107

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer Cash Conversion Cycle Price % 24h Market Cap Country
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
46.6 $ 330.34 3.6 % $ 43.3 B usaUSA
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
130 $ 0.44 -16.64 % $ 5.04 M israelIsrael
I-Mab I-Mab
IMAB
-1.97 K - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
120 $ 24.98 1.17 % $ 3.05 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
82.8 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
17 - -1.52 % $ 24.7 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
294 $ 1.58 - $ 106 M usaUSA
Curis Curis
CRIS
103 $ 0.53 -3.07 % $ 6.98 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
117 - -24.86 % $ 820 K usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
-4.27 K $ 37.7 1.26 % $ 3.55 B usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
1.1 K $ 49.15 -0.73 % $ 4.42 B schweizSchweiz
Advaxis Advaxis
ADXS
-143 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-34.3 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
AIkido Pharma AIkido Pharma
AIKI
-1.92 - 1.93 % $ 17.4 M usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
12.2 $ 4.4 -3.51 % $ 607 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Cue Biopharma Cue Biopharma
CUE
43.1 $ 0.18 -1.61 % $ 17.1 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
-172 $ 4.09 -0.97 % $ 437 M usaUSA
Cyclerion Therapeutics Cyclerion Therapeutics
CYCN
120 $ 4.15 -32.52 % $ 10.4 M usaUSA
Daré Bioscience Daré Bioscience
DARE
-1.64 K $ 1.81 4.02 % $ 20.2 M usaUSA
DBV Technologies S.A. DBV Technologies S.A.
DBVT
71.3 $ 20.36 -3.32 % $ 2.84 B franceFrance
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
21.2 $ 8.22 2.37 % $ 225 M israelIsrael
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Denali Therapeutics Denali Therapeutics
DNLI
1.89 $ 19.38 -6.15 % $ 3.19 B usaUSA
Dyadic International Dyadic International
DYAI
-26.6 $ 0.87 -2.8 % $ 31.5 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
-58 - - $ 96.9 B britainBritain
Celldex Therapeutics Celldex Therapeutics
CLDX
-3.74 K $ 31.37 1.0 % $ 2.08 B usaUSA